Read about how MS is diagnosed and treated, lifestyle issues, and how to make informed decisions about disclosure, and more.
- The Disease-Modifying Drugs (.pdf)
Information on the disease-modifying drugs (Avonex®, Betaseron®, Copaxone®, Extavia®, Novantrone®, Rebif® and Tysabri®). Includes how each is taken, side effects, benefits, and available help (updated October 30, 2009).
- Diagnosis: The Basic Facts (.pdf)
Explains usual steps and tests. Includes how to prepare for an MRI (last updated 2006).
- Disclosure: The Basic Facts (.pdf)
Discusses whom, when, and how to tell in both personal and work situations; includes personal vignettes (last updated 2004).
- Living with MS (.pdf)
Addresses questions frequently asked after diagnosis of MS is received—from possible causes to advice on coping. By Debra Frankel, MS, OTR, with Hettie Jones (last updated January 2009).
For printed copies of any of our materials, contact your chapter or call 1-800-344-4867.
—
Avonex is a registered trademark of Biogen Idec.
Betaseron is a registered trademark of Bayer Schering Pharma AG.
Copaxone is a registered trademark of Teva Pharmaceutical Industries Ltd.
Novantrone is a registered trademark of Immunex Corp.
Rebif is a registered trademark of Ares Trading, S.A.
Tysabri is a registered trademark of Elan Pharmaceuticals, Inc.